Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Acurx Pharmaceuticals Inc (NQ: ACXP )

2.120 +0.020 (+0.95%)
Streaming Delayed Price Updated: 3:59 PM EDT, Sep 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 59,729
Open 2.110
Bid (Size) 2.100 (1)
Ask (Size) 2.150 (1)
Prev. Close 2.100
Today's Range 2.030 - 2.140
52wk Range 1.170 - 8.820
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ACXP Stock Earnings: Acurx Pharmaceuticals Misses EPS for Q2 2024
ACXP stock results show that Acurx Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga

Performance

YTD
-47.00%
-47.00%
1 Month
+9.28%
+9.28%
3 Month
-13.47%
-13.47%
6 Month
-29.33%
-29.33%
1 Year
+19.48%
+19.48%

More News

Read More
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
A Preview Of Acurx Pharmaceuticals's Earnings
Via Benzinga
Acurx Pharmaceuticals: Q3 Earnings Insights
Via Benzinga
ACXP Stock Earnings: Acurx Pharmaceuticals Misses EPS for Q1 2024
Via InvestorPlace
Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
ACXP Stock Earnings: Acurx Pharmaceuticals Misses EPS for Q4 2023
Via InvestorPlace
Earnings Scheduled For March 18, 2024
Via Benzinga
New to the Street TV Series on Bloomberg and Fox Business, Innovative Companies Spotlighted: ACXP, TNXP, PETV, SWISF, GEVI, CLNV
Via AB Newswire
Acurx Pharmaceuticals’ Phase 2b Results For Ibezapolstat Bests Standard Of Care Vancomycin To Treat C. Difficile ($ACXP)
Via AB Newswire
Exposures Product Safety
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today?
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Acurx's Antibiotic Shows All Patients With Clinical Cure Remained Infection-Free After End Of Treatment
Via Benzinga
Why BEST Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.